Strides Pharma Science is currently trading at Rs. 461.05, up by 3.75 points or 0.82% from its previous closing of Rs. 457.30 on the BSE.
The scrip opened at Rs. 455.50 and has touched a high and low of Rs. 461.95 and Rs. 446.85 respectively. So far 55725 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 875.72 on 27-Dec-2017 and a 52 week low of Rs. 334.10 on 08-Jun-2018.
Last one week high and low of the scrip stood at Rs. 487.90 and Rs. 446.85 respectively. The current market cap of the company is Rs. 4124.62 crore.
The promoters holding in the company stood at 30.79%, while Institutions and Non-Institutions held 47.54% and 21.68% respectively.
Strides Pharma Science has completed investment in Strides Consumer Healthcare Business. India Life Sciences Fund III advised by ICP-III Investment Advisors has partnered with Strides and the said transaction has achieved closure on December 20, 2018.
The company had earlier announced about partnering with ICP-III Investment Advisors for funding in its nascent Consumer Healthcare Business.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
